Author:
Li Mengfang,Li Qingqing,Lin Dan,Zheng Xiang,Jin Lehao,Cai Jianping,Hu Guoxin,Qian Jianchang
Funder
Natural Science Foundation of Zhejiang Province
National Key Research and Development Program of China
Wenzhou Medical University
National Natural Science Foundation of China
Reference33 articles.
1. Drug metabolism in the liver;Almazroo;Clin. Liver Dis.,2017
2. Evaluation of recombinant CYP3A4 variants on the metabolism of oxycodone in vitro;Cai;Chem. Res. Toxicol.,2021
3. GC-MS quantification of ketamine, norketamine, and dehydronorketamine in urine specimens and comparative study using ELISA as the preliminary test methodology;Cheng;J. Chromatogr. B Anal. Technol. Biomed. Life Sci.,2007
4. Ketamine use for cancer and chronic pain management;Culp;Front Pharm.,2020
5. Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos;Dai;J. Pharm. Exp. Ther.,2001